Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6.145 USD | -2.46% | +9.82% | -5.15% |
May. 20 | Top Premarket Decliners | MT |
Mar. 06 | Transcript : ESSA Pharma Inc. - Shareholder/Analyst Call |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 382M 278M |
---|---|---|---|---|---|
Net income 2024 * | -46M -33.49M | Net income 2025 * | -72M -52.42M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-8.34
x | P/E ratio 2025 * |
-6.21
x | Employees | 50 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.73% |
Latest transcript on ESSA Pharma Inc.
1 day | +1.61% | ||
1 week | +0.80% | ||
Current month | -2.02% | ||
1 month | -1.56% | ||
3 months | -20.05% | ||
6 months | +12.70% | ||
Current year | -4.55% |
Managers | Title | Age | Since |
---|---|---|---|
David Parkinson
CEO | Chief Executive Officer | 73 | 15-06-23 |
David Wood
DFI | Director of Finance/CFO | 66 | 13-09-30 |
Peter Virsik
COO | Chief Operating Officer | - | 16-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Franklin Berger
BRD | Director/Board Member | 74 | 15-03-04 |
Sanford Zweifach
BRD | Director/Board Member | 68 | 19-07-30 |
Richard Glickman
CHM | Chairman | 65 | 10-09-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 6.145 | -2.46% | 54 953 |
24-05-23 | 6.3 | +1.61% | 52,377 |
24-05-22 | 6.2 | 0.00% | 58,552 |
24-05-21 | 6.2 | -0.64% | 74,780 |
24-05-20 | 6.24 | +9.47% | 158,068 |
Delayed Quote Nasdaq, May 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.55% | 279M | |
+64.92% | 62.86B | |
-1.85% | 41.38B | |
+44.76% | 40.38B | |
-8.93% | 27.64B | |
+13.05% | 26.46B | |
-21.96% | 18.9B | |
+4.21% | 12.67B | |
+25.74% | 12.27B | |
+27.42% | 12.07B |
- Stock Market
- Equities
- EPIX Stock